Dna X (SONM) Enterprise Value (2018 - 2025)
Dna X (SONM) has disclosed Enterprise Value for 8 consecutive years, with -$2.1 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 76.41% year-over-year to -$2.1 million, compared with a TTM value of -$2.1 million through Sep 2025, up 76.41%, and an annual FY2024 reading of -$8.0 million, down 2588.96% over the prior year.
- Enterprise Value was -$2.1 million for Q3 2025 at Dna X, up from -$5.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$299000.0 in Q4 2023 and bottomed at -$15.5 million in Q3 2022.
- Average Enterprise Value over 5 years is -$8.0 million, with a median of -$8.5 million recorded in 2023.
- The sharpest move saw Enterprise Value soared 97.74% in 2023, then crashed 2588.96% in 2024.
- Year by year, Enterprise Value stood at -$2.5 million in 2021, then crashed by 419.99% to -$13.2 million in 2022, then skyrocketed by 97.74% to -$299000.0 in 2023, then plummeted by 2588.96% to -$8.0 million in 2024, then skyrocketed by 73.42% to -$2.1 million in 2025.
- Business Quant data shows Enterprise Value for SONM at -$2.1 million in Q3 2025, -$5.4 million in Q2 2025, and -$4.9 million in Q1 2025.